Kakishita E et al. |
Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood. |
1990 |
Thromb. Res. |
pmid:2082481
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Chang GT et al. |
Purification and characterization of a new anticoagulant protein, PP27, from placenta. |
2005 |
Thromb. Res. |
pmid:16122555
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Simon MF et al. |
Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. |
1987 |
Thromb. Res. |
pmid:3576518
|
Bochkov VN et al. |
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. |
1991 |
Thromb. Res. |
pmid:2063348
|
Alam I and Silver MJ |
Metabolism of 1-alkyl-2-acyl-GPC in human platelets in response to stimulation by thrombin. |
1987 |
Thromb. Res. |
pmid:3576519
|
Liu X et al. |
Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. |
2014 |
Thromb. Res. |
pmid:25223809
|
Hanss M and Dechavanne M |
48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. |
1988 |
Thromb. Res. |
pmid:3126559
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Bretschneider E et al. |
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations. |
1994 |
Thromb. Res. |
pmid:7992234
|
Jones KP et al. |
Salivary PAF in acute myocardial infarction and angina: changes during hospital treatment and relationship to cardiac enzymes. |
1994 |
Thromb. Res. |
pmid:7992251
|
Namm DH et al. |
Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine. |
1982 |
Thromb. Res. |
pmid:7071810
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Violi F et al. |
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. |
1989 |
Thromb. Res. |
pmid:2506658
|
Kurose I et al. |
Involvement of superoxide anion and platelet-activating factor in increased tissue-type plasminogen activator during rat gastric microvascular damages. |
1991 |
Thromb. Res. |
pmid:1650966
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Brown JE and Thuy LP |
The binding of bovine platelet aggregating factor to human platelets. |
1981 Apr 1-15 |
Thromb. Res. |
pmid:7292446
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. |
1987 |
Thromb. Res. |
pmid:3647677
|
Valone FH |
Platelet-activating factor binding and metabolism during human platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3400077
|
Sloan IG and Firkin BG |
Impaired fibrinolysis in patients with thrombotic or haemostatic defects. |
1989 |
Thromb. Res. |
pmid:2814943
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Lalau Keraly C et al. |
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets. |
1984 |
Thromb. Res. |
pmid:6740569
|
Suttorp N et al. |
Stimulation of PAF-synthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha-toxin. |
1992 |
Thromb. Res. |
pmid:1440526
|
Bernat A and Herbert JM |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF. |
1994 |
Thromb. Res. |
pmid:8073411
|
Pletscher A et al. |
LDL induced shape change reaction of platelets is not due to PAF. |
1989 |
Thromb. Res. |
pmid:2609294
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Valone FH and Johnson B |
Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability. |
1985 |
Thromb. Res. |
pmid:4082115
|
Kawamura M et al. |
Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation. |
1993 |
Thromb. Res. |
pmid:8332959
|
Joseph R et al. |
Platelet-activating factor and red blood cells. |
1989 |
Thromb. Res. |
pmid:2734734
|
Ostermann G et al. |
The role of lipoproteins in the degradation of platelet-activating factor. |
1986 |
Thromb. Res. |
pmid:3798402
|
Stormorken H et al. |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). |
1983 |
Thromb. Res. |
pmid:6857589
|
Kloprogge E et al. |
Stimulus-response coupling in human platelets. Evidence against a role of PAF-acether in the "third pathway'. |
1983 |
Thromb. Res. |
pmid:6857605
|
Battistini B et al. |
Endothelin-1 does not affect human platelet aggregation in whole blood and platelet rich plasma. |
1990 |
Thromb. Res. |
pmid:2278035
|
Ostermann G et al. |
Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids. |
1991 |
Thromb. Res. |
pmid:2028445
|
Joseph R et al. |
Endothelin-1 and human platelet activity. |
1991 |
Thromb. Res. |
pmid:2028454
|
Garcia JG et al. |
Effect of platelet activating factor on leukocyte-endothelial cell interactions. |
1988 |
Thromb. Res. |
pmid:2842887
|
Suzuki K et al. |
The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:6966083
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Ostermann G et al. |
Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. |
1986 |
Thromb. Res. |
pmid:3764811
|
Ostermann G et al. |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. |
1988 |
Thromb. Res. |
pmid:3232123
|
Avdonin PV et al. |
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. |
1988 |
Thromb. Res. |
pmid:3232128
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Avdonin PV et al. |
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. |
1987 |
Thromb. Res. |
pmid:2438805
|
Kinlough-Rathbone RL et al. |
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. |
1999 |
Thromb. Res. |
pmid:10527409
|
Csáki C et al. |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. |
1992 |
Thromb. Res. |
pmid:1412179
|
Patterson WR et al. |
Aggregation of killer whale platelets. |
1993 |
Thromb. Res. |
pmid:8327987
|